Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 113

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 113
---
 set the strategic direction for Samsung Group’s diverse business
portfolio. He was previously the Chief Strategy Officer for Merck from October 2011 to March 2014, and Tyco Electronics from June 2009
to October 2011, and Lenovo from December 2007 to March 2009. Mr. Do is a former senior partner at McKinsey & Company, where he spent
17 years and helped build the healthcare, high tech and corporate finance practices. He holds a BA from Dartmouth College, and an MBA
from the Tuck School of Business at Dartmouth.

We believe Mr. Do’s qualifications to serve on our Board of Directors
and as the CEO are primarily based on his decades of experience as an executive in the pharma, biotech, and other high technology industries
and his extensive experience in strategy, corporate finance practice and the development of companies in all stages.

Ms. Joanne Wendy Kim has served as the Company’s Chief
Financial Officer since October 2018. Ms. Kim previously served as CFO for several companies throughout her career, previously with Landmark
Education Enterprises, and prior to that, other public entities in the entertainment and financial services industry sectors. She provided
interim CFO services to various organizations through Group JWK from 2016 to 2018. In her various roles, Ms. Kim oversaw corporate finance
and operational groups, closed eight acquisitions, secured bank financings, developed and implemented new business strategies, managed
risk and implemented new financial policies and procedures. As a CPA professional, she advised on accounting transactions, SEC reporting
matters and other regulatory matters to clients serving as a Director at BDO USA, LLP’s National Office SEC Department and sat the
US desk in London for BDO LLP UK Firm in 2008-2016 and as a Senior Manager at KPMG in earlier part of her career. She brings more than
35 years of accounting and finance experience to this position. Ms. Kim earned her BSA in accounting and finance at California State University,
Long Beach.

Wendy Kim’s qualifications to serve as our Chief Financial Officer
are primarily based on her 35 years of accounting and finance experience both as a CFO and as a CPA in major global accounting and consultancy
firms.

Dr. Joseph M. Palumbo has served as our Chief Medical Officer
since November 2021. Formerly he served as the CMO at Zynerba Pharmaceuticals from July 2019 to October 2021, responsible for